Literature DB >> 21522327

6-Chloro-2-cyclo-propyl-4-(trifluoro-meth-yl)quinoline.

H C Devarajegowda, H K Arunkashi, Suresh Babu Vepuri, N Chidananda, V D Jagadeesh Prasad.   

Abstract

In the title compound, C(13)H(9)ClF(3)N, the quinoline ring system makes a dihedral angle of 88.8 (2)° with the cyclo-propyl ring.

Entities:  

Year:  2011        PMID: 21522327      PMCID: PMC3051946          DOI: 10.1107/S1600536811003746

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For general background to quinolines see: Kayser & Novak (1987 ▶); Rudin et al. (1984 ▶); Mao et al. (2009 ▶); Bermudez et al. (2004 ▶); Jayaprakash et al. (2006 ▶); Andries et al. (2005 ▶). For related structures, see: Skörska et al. (2005 ▶); Devarajegowda et al. (2010 ▶); Li et al. (2005 ▶).

Experimental

Crystal data

C13H9ClF3N M = 271.66 Monoclinic, a = 13.8482 (19) Å b = 5.0534 (8) Å c = 18.048 (3) Å β = 107.503 (17)° V = 1204.5 (3) Å3 Z = 4 Mo Kα radiation μ = 0.33 mm−1 T = 293 K 0.22 × 0.15 × 0.12 mm

Data collection

Oxford Diffraction Xcalibur diffractometer Absorption correction: multi-scan (CrysAlis PRO RED; Oxford Diffraction, 2010 ▶) T min = 0.942, T max = 0.961 11631 measured reflections 2105 independent reflections 946 reflections with I > 2σ(I) R int = 0.092

Refinement

R[F 2 > 2σ(F 2)] = 0.041 wR(F 2) = 0.081 S = 0.78 2105 reflections 164 parameters H-atom parameters constrained Δρmax = 0.13 e Å−3 Δρmin = −0.17 e Å−3 Data collection: CrysAlis PRO CCD (Oxford Diffraction, 2010 ▶); cell refinement: CrysAlis PRO CCD; data reduction: CrysAlis PRO RED (Oxford Diffraction, 2010 ▶); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 (Farrugia, 1997 ▶) and CAMERON (Watkin et al., 1993) ▶; software used to prepare material for publication: WinGX (Farrugia, 1999 ▶). Crystal structure: contains datablocks I, global. DOI: 10.1107/S1600536811003746/wn2420sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536811003746/wn2420Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C13H9ClF3NF(000) = 552
Mr = 271.66Dx = 1.498 Mg m3
Monoclinic, P21/cMelting point: 335 K
Hall symbol: -P 2ybcMo Kα radiation, λ = 0.71073 Å
a = 13.8482 (19) ÅCell parameters from 2105 reflections
b = 5.0534 (8) Åθ = 2.4–25.0°
c = 18.048 (3) ŵ = 0.33 mm1
β = 107.503 (17)°T = 293 K
V = 1204.5 (3) Å3Plate, colourless
Z = 40.22 × 0.15 × 0.12 mm
Oxford Diffraction Xcalibur diffractometer2105 independent reflections
Radiation source: Enhance (Mo) X-ray Source946 reflections with I > 2σ(I)
graphiteRint = 0.092
Detector resolution: 16.0839 pixels mm-1θmax = 25.0°, θmin = 2.4°
ω scansh = −16→16
Absorption correction: multi-scan (CrysAlis PRO RED; Oxford Diffraction, 2010)k = −6→6
Tmin = 0.942, Tmax = 0.961l = −21→21
11631 measured reflections
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.041H-atom parameters constrained
wR(F2) = 0.081w = 1/[σ2(Fo2) + (0.0334P)2] where P = (Fo2 + 2Fc2)/3
S = 0.78(Δ/σ)max = 0.004
2105 reflectionsΔρmax = 0.13 e Å3
164 parametersΔρmin = −0.17 e Å3
0 restraintsExtinction correction: SHELXL97 (Sheldrick, 2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Primary atom site location: structure-invariant direct methodsExtinction coefficient: 0.0045 (8)
Experimental. CrysAlis PRO, Oxford Diffraction Ltd., Version 1.171.33.55 (release 05–01–2010 CrysAlis171. NET) Empirical absorption correction using spherical harmonics, implemented in SCALE3 ABSPACK scaling algorithm.
Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Cl10.24504 (7)−0.53695 (16)0.14138 (5)0.0724 (3)
F10.53230 (12)0.2294 (4)0.43406 (12)0.1017 (8)
F20.49335 (13)0.1618 (4)0.31203 (13)0.0964 (7)
F30.49773 (12)−0.1595 (4)0.38888 (11)0.0896 (7)
N90.15811 (17)0.2481 (4)0.35357 (14)0.0463 (6)
C10.1215 (2)0.4767 (6)0.49521 (17)0.0629 (9)
H1A0.08460.31370.47790.076*
H1B0.13000.52280.54900.076*
C20.2051 (2)0.5449 (6)0.46255 (18)0.0612 (9)
H20.26230.63980.49800.073*
C30.1078 (2)0.6908 (6)0.43962 (19)0.0695 (10)
H3A0.10770.87010.45880.083*
H3B0.06240.66100.38780.083*
C40.2319 (2)0.3623 (5)0.40752 (17)0.0486 (8)
C50.3343 (2)0.3113 (6)0.41542 (17)0.0542 (9)
H50.38430.39780.45400.065*
C60.3612 (2)0.1390 (6)0.36802 (17)0.0463 (8)
C70.2855 (2)0.0029 (5)0.30968 (16)0.0401 (7)
C80.1844 (2)0.0691 (5)0.30551 (16)0.0405 (7)
C100.4703 (3)0.0937 (8)0.3759 (2)0.0678 (10)
C110.3025 (2)−0.1850 (5)0.25749 (16)0.0452 (8)
H110.3683−0.22900.25910.054*
C120.2229 (2)−0.3017 (5)0.20490 (16)0.0456 (8)
C130.1232 (2)−0.2394 (6)0.19959 (16)0.0489 (8)
H130.0699−0.32290.16300.059*
C140.1044 (2)−0.0553 (6)0.24840 (16)0.0464 (8)
H140.0378−0.01050.24420.056*
U11U22U33U12U13U23
Cl10.0857 (7)0.0722 (6)0.0640 (6)−0.0003 (5)0.0296 (5)−0.0188 (5)
F10.0448 (12)0.1346 (18)0.1136 (18)−0.0181 (12)0.0057 (12)−0.0505 (15)
F20.0542 (13)0.148 (2)0.1014 (19)−0.0123 (12)0.0445 (12)0.0029 (14)
F30.0516 (12)0.0939 (15)0.1143 (18)0.0143 (11)0.0113 (11)−0.0095 (13)
N90.0436 (15)0.0528 (16)0.0448 (16)−0.0020 (14)0.0165 (13)−0.0026 (14)
C10.085 (3)0.058 (2)0.057 (2)0.0067 (19)0.0374 (19)−0.0017 (19)
C20.049 (2)0.071 (2)0.066 (2)−0.0092 (19)0.0205 (19)−0.024 (2)
C30.095 (3)0.051 (2)0.068 (3)0.011 (2)0.032 (2)0.0001 (19)
C40.044 (2)0.055 (2)0.051 (2)−0.0035 (17)0.0208 (18)−0.0058 (17)
C50.044 (2)0.063 (2)0.054 (2)−0.0126 (17)0.0135 (17)−0.0157 (17)
C60.037 (2)0.055 (2)0.049 (2)0.0002 (16)0.0153 (17)−0.0012 (16)
C70.036 (2)0.0463 (19)0.0404 (18)−0.0017 (15)0.0158 (15)0.0033 (16)
C80.044 (2)0.0452 (18)0.0351 (18)−0.0051 (16)0.0169 (16)0.0028 (15)
C100.051 (3)0.078 (3)0.077 (3)−0.003 (2)0.023 (2)−0.013 (2)
C110.0381 (19)0.0523 (19)0.049 (2)0.0010 (16)0.0191 (17)0.0017 (17)
C120.053 (2)0.0478 (19)0.0413 (19)−0.0054 (17)0.0221 (17)−0.0045 (15)
C130.045 (2)0.055 (2)0.046 (2)−0.0110 (17)0.0128 (17)−0.0012 (17)
C140.0364 (18)0.056 (2)0.048 (2)−0.0007 (16)0.0144 (17)−0.0033 (17)
Cl1—C121.741 (3)C4—C51.406 (4)
F1—C101.329 (3)C5—C61.349 (3)
F2—C101.330 (4)C5—H50.9300
F3—C101.335 (3)C6—C71.420 (3)
N9—C41.314 (3)C6—C101.492 (4)
N9—C81.376 (3)C7—C111.406 (3)
C1—C31.449 (4)C7—C81.419 (3)
C1—C21.490 (4)C8—C141.413 (3)
C1—H1A0.9700C11—C121.354 (3)
C1—H1B0.9700C11—H110.9300
C2—C31.481 (4)C12—C131.392 (3)
C2—C41.482 (4)C13—C141.359 (3)
C2—H20.9800C13—H130.9300
C3—H3A0.9700C14—H140.9300
C3—H3B0.9700
C4—N9—C8117.5 (3)C5—C6—C10120.2 (3)
C3—C1—C260.5 (2)C7—C6—C10119.8 (3)
C3—C1—H1A117.7C11—C7—C8119.0 (3)
C2—C1—H1A117.7C11—C7—C6126.1 (3)
C3—C1—H1B117.7C8—C7—C6114.9 (3)
C2—C1—H1B117.7N9—C8—C14117.0 (3)
H1A—C1—H1B114.8N9—C8—C7124.4 (3)
C3—C2—C4120.8 (3)C14—C8—C7118.6 (3)
C3—C2—C158.35 (19)F1—C10—F2106.5 (3)
C4—C2—C1120.1 (3)F1—C10—F3105.9 (3)
C3—C2—H2115.3F2—C10—F3105.7 (3)
C4—C2—H2115.3F1—C10—C6113.0 (3)
C1—C2—H2115.3F2—C10—C6112.2 (3)
C1—C3—C261.12 (19)F3—C10—C6113.0 (3)
C1—C3—H3A117.7C12—C11—C7119.9 (3)
C2—C3—H3A117.7C12—C11—H11120.0
C1—C3—H3B117.7C7—C11—H11120.0
C2—C3—H3B117.7C11—C12—C13122.1 (3)
H3A—C3—H3B114.8C11—C12—Cl1119.5 (2)
N9—C4—C5122.0 (3)C13—C12—Cl1118.5 (2)
N9—C4—C2118.4 (3)C14—C13—C12119.3 (3)
C5—C4—C2119.6 (3)C14—C13—H13120.3
C6—C5—C4121.1 (3)C12—C13—H13120.3
C6—C5—H5119.4C13—C14—C8121.1 (3)
C4—C5—H5119.4C13—C14—H14119.5
C5—C6—C7120.0 (3)C8—C14—H14119.5
C3—C1—C2—C4−109.7 (3)C6—C7—C8—N9−0.6 (4)
C4—C2—C3—C1108.6 (3)C11—C7—C8—C14−0.5 (4)
C8—N9—C4—C51.6 (4)C6—C7—C8—C14179.3 (2)
C8—N9—C4—C2−176.8 (2)C5—C6—C10—F12.5 (5)
C3—C2—C4—N9−27.5 (4)C7—C6—C10—F1−178.5 (3)
C1—C2—C4—N941.4 (4)C5—C6—C10—F2−118.0 (3)
C3—C2—C4—C5154.1 (3)C7—C6—C10—F261.0 (4)
C1—C2—C4—C5−137.1 (3)C5—C6—C10—F3122.6 (3)
N9—C4—C5—C6−0.8 (5)C7—C6—C10—F3−58.3 (4)
C2—C4—C5—C6177.6 (3)C8—C7—C11—C12−0.7 (4)
C4—C5—C6—C7−0.9 (4)C6—C7—C11—C12179.5 (3)
C4—C5—C6—C10178.2 (3)C7—C11—C12—C130.9 (4)
C5—C6—C7—C11−178.7 (3)C7—C11—C12—Cl1−179.23 (19)
C10—C6—C7—C112.2 (4)C11—C12—C13—C140.2 (4)
C5—C6—C7—C81.5 (4)Cl1—C12—C13—C14−179.7 (2)
C10—C6—C7—C8−177.6 (3)C12—C13—C14—C8−1.5 (4)
C4—N9—C8—C14179.1 (2)N9—C8—C14—C13−178.4 (2)
C4—N9—C8—C7−0.9 (4)C7—C8—C14—C131.6 (4)
C11—C7—C8—N9179.5 (2)
  9 in total

1.  A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Authors:  Koen Andries; Peter Verhasselt; Jerome Guillemont; Hinrich W H Göhlmann; Jean-Marc Neefs; Hans Winkler; Jef Van Gestel; Philip Timmerman; Min Zhu; Ennis Lee; Peter Williams; Didier de Chaffoy; Emma Huitric; Sven Hoffner; Emmanuelle Cambau; Chantal Truffot-Pernot; Nacer Lounis; Vincent Jarlier
Journal:  Science       Date:  2004-12-09       Impact factor: 47.728

2.  Design, synthesis, and SAR studies of mefloquine-based ligands as potential antituberculosis agents.

Authors:  Sarva Jayaprakash; Yasuyoshi Iso; Baojie Wan; Scott G Franzblau; Alan P Kozikowski
Journal:  ChemMedChem       Date:  2006-06       Impact factor: 3.466

3.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

4.  Conformation stability and organization of mefloquine molecules in different environments.

Authors:  Agnieszka Skórska; Jan Sliwiński; Barbara J Oleksyn
Journal:  Bioorg Med Chem Lett       Date:  2005-11-21       Impact factor: 2.823

5.  SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.

Authors:  Luiz E Bermudez; Peter Kolonoski; Lianne E Seitz; Mary Petrofsky; Robert Reynolds; Martin Wu; Lowell S Young
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 6.  In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.

Authors:  F H Kayser; J Novak
Journal:  Am J Med       Date:  1987-04-27       Impact factor: 4.965

7.  From serendipity to rational antituberculosis drug discovery of mefloquine-isoxazole carboxylic acid esters.

Authors:  Jialin Mao; Hai Yuan; Yuehong Wang; Baojie Wan; Marco Pieroni; Qingqing Huang; Richard B van Breemen; Alan P Kozikowski; Scott G Franzblau
Journal:  J Med Chem       Date:  2009-11-26       Impact factor: 7.446

8.  In vitro activity of ciprofloxacin against aerobic gram-negative bacteria.

Authors:  J E Rudin; C W Norden; E M Shinners
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

9.  Nicotinaldehyde [2,8-bis-(trifluoro-meth-yl)quinolin-4-yl]hydrazone monohydrate.

Authors:  H C Devarajegowda; Suresh Babu Vepuri; M Vinduvahini; H D Kavitha; H K Arunkashi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-11
  9 in total
  1 in total

1.  1,1',1'',1'''-(Oxydi-methane-tri-yl)tetra-kis-(4-fluoro-benzene).

Authors:  K R Roopashree; H D Kavitha; K S Katagi; O Kotresh; H C Devarajegowda
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2014-03-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.